News Daily News Faulting Salt? New PURE Analysis Argues Against Low Sodium Intake Todd Neale August 10, 2018
News Daily News FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen Michael O'Riordan July 16, 2018
News Daily News Uphill Climb Seen for Implementation of US Blood Pressure Guidelines Todd Neale July 12, 2018
News Daily News New CARDIA Data: 75% of African-Americans Have Hypertension by Age 55 L.A. McKeown July 11, 2018
News Daily News ‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes Yael L. Maxwell June 29, 2018
News Daily News Reduction in CVD Events, Even Mortality, in Patients With Diabetes Who Adopt a Healthier Lifestyle Michael O'Riordan June 18, 2018
News Daily News Whitehall II: Systolic BP Above 130 mm Hg at Age 50 Heightens Risk of Dementia L.A. McKeown June 13, 2018
News Daily News New European Hypertension Guidelines Not in Harmony With US Guidance Todd Neale June 11, 2018
News Daily News Obesity Not Benign: Higher Risk of CVD Seen With Excess Weight Michael O'Riordan June 05, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2018 Caitlin E. Cox June 01, 2018
News Daily News Financial Burden of Hypertension Weighs Heavily on US Population Todd Neale May 30, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Daily News Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests L.A. McKeown May 23, 2018
Presentation EuroPCR 2018 Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial Presenter: David E. Kandzari May 23, 2018
News Daily News Hypertension During Pregnancy Linked With Subsequent A-fib in Women Yael L. Maxwell May 18, 2018
News Industry News ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris May 17, 2018
News Daily News PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations Michael O'Riordan May 10, 2018
News Industry News Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease May 08, 2018
News Conference News EAS 2018 Biology in the Back Seat: EAS 2018 Opens With Calls for a Big-Picture Approach to CVD Prevention Yael L. Maxwell May 07, 2018